{"transactions":[{"id":1208400,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2025-03-13T20:30:51.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1180,"price":23.95,"value":28261.0,"ownership":{"direct":true},"balance_after":56020,"source":{"system":"sec-edgar","filing":"0000917520-25-000029","document":"wk-form4_1741897845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000029/wk-form4_1741897845.xml","form_type":"4"}},{"id":1208399,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2025-03-13T20:30:51.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1538,"price":23.95,"value":36835.1,"ownership":{"direct":true},"balance_after":57200,"source":{"system":"sec-edgar","filing":"0000917520-25-000029","document":"wk-form4_1741897845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000029/wk-form4_1741897845.xml","form_type":"4"}},{"id":1213465,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2025-03-11T20:28:44.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":773,"price":22.61,"value":17477.53,"ownership":{"direct":true},"balance_after":58738,"source":{"system":"sec-edgar","filing":"0000917520-25-000020","document":"wk-form4_1741724916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000020/wk-form4_1741724916.xml","form_type":"4"}},{"id":1343720,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-12-04T21:32:36.000Z","date":"2024-12-03","kind":"sale","planned":false,"acquired":false,"shares":4070,"price":24.595,"value":100101.65,"ownership":{"direct":true},"balance_after":59511,"source":{"system":"sec-edgar","filing":"0000917520-24-000112","document":"wk-form4_1733347945.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000112/wk-form4_1733347945.xml","form_type":"4"}},{"id":1579415,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":17890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024."}],"balance_after":17890,"derivative":{"exercise_price":36.22,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":17890},"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1579414,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":348,"price":35.88,"value":12486.24,"ownership":{"direct":true},"balance_after":63581,"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1579413,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1090,"price":35.88,"value":39109.2,"ownership":{"direct":true},"balance_after":63929,"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1579412,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":8283,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65019,"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1579411,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":7745,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56736,"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1579410,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-13T20:28:19.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1371,"price":36.22,"value":49657.62,"ownership":{"direct":true},"balance_after":48991,"source":{"system":"sec-edgar","filing":"0000917520-24-000034","document":"wk-form4_1710361689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000034/wk-form4_1710361689.xml","form_type":"4"}},{"id":1582263,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-03-12T21:14:31.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":799,"price":36.73,"value":29347.27,"ownership":{"direct":true},"balance_after":50362,"source":{"system":"sec-edgar","filing":"0000917520-24-000027","document":"wk-form4_1710278042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000027/wk-form4_1710278042.xml","form_type":"4"}},{"id":1626578,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2024-02-22T21:45:56.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date."}],"balance_after":51161,"source":{"system":"sec-edgar","filing":"0000917520-24-000005","document":"wk-form4_1708638320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000005/wk-form4_1708638320.xml","form_type":"4"}},{"id":1868141,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-06-05T20:12:01.000Z","date":"2023-06-01","kind":"purchase","planned":false,"acquired":true,"shares":2640,"price":37.8921,"value":100035.144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price shown above represents the weighted average price of the shares purchased. The range of the purchase prices was $37.875 to $37.92. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":48597,"source":{"system":"sec-edgar","filing":"0001209191-23-034263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123034263/doc4.xml","form_type":"4"}},{"id":1955260,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":12419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023."}],"balance_after":12419,"derivative":{"exercise_price":52.87,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":12419},"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955259,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":416,"price":62.61,"value":26045.76,"ownership":{"direct":true},"balance_after":45957,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955258,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":915,"price":52.61,"value":48138.15,"ownership":{"direct":true},"balance_after":46373,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955257,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":338,"price":52.87,"value":17870.06,"ownership":{"direct":true},"balance_after":47288,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955256,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":238,"price":52.87,"value":12583.06,"ownership":{"direct":true},"balance_after":47626,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955255,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":594,"price":52.87,"value":31404.78,"ownership":{"direct":true},"balance_after":47864,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955254,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":1371,"price":52.87,"value":72484.77,"ownership":{"direct":true},"balance_after":48458,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955253,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":2393,"price":52.87,"value":126517.91,"ownership":{"direct":true},"balance_after":49829,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":1955252,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:16:49.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":5070,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52222,"source":{"system":"sec-edgar","filing":"0001209191-23-018435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018435/doc4.xml","form_type":"4"}},{"id":2014182,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-02-15T21:30:40.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":5641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date."}],"balance_after":47152,"source":{"system":"sec-edgar","filing":"0001209191-23-009748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009748/doc4.xml","form_type":"4"}},{"id":2014181,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-02-15T21:30:40.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date."}],"balance_after":41511,"source":{"system":"sec-edgar","filing":"0001209191-23-009748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009748/doc4.xml","form_type":"4"}},{"id":2014180,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-02-15T21:30:40.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date."}],"balance_after":40111,"source":{"system":"sec-edgar","filing":"0001209191-23-009748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009748/doc4.xml","form_type":"4"}},{"id":2014179,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2023-02-15T21:30:40.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":2156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date."}],"balance_after":39551,"source":{"system":"sec-edgar","filing":"0001209191-23-009748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009748/doc4.xml","form_type":"4"}},{"id":2334167,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":true,"shares":27539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."}],"balance_after":27539,"derivative":{"exercise_price":65.11,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":27539},"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334166,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":1488,"price":65.11,"value":96883.68,"ownership":{"direct":true},"balance_after":37395,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334165,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":691,"price":65.11,"value":44991.01,"ownership":{"direct":true},"balance_after":38883,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334164,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":286,"price":65.11,"value":18621.46,"ownership":{"direct":true},"balance_after":39574,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334163,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":404,"price":65.11,"value":26304.44,"ownership":{"direct":true},"balance_after":39860,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334162,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":349,"price":65.11,"value":22723.39,"ownership":{"direct":true},"balance_after":40264,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334161,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":873,"price":65.11,"value":56841.03,"ownership":{"direct":true},"balance_after":40613,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334160,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":218,"price":65.11,"value":14193.98,"ownership":{"direct":true},"balance_after":41486,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2334159,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-15T20:41:15.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":9792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41704,"source":{"system":"sec-edgar","filing":"0001209191-22-018842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018842/doc4.xml","form_type":"4"}},{"id":2356825,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-03-03T23:06:43.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":1712,"price":66.32,"value":113539.84,"ownership":{"direct":true},"balance_after":31912,"source":{"system":"sec-edgar","filing":"0001209191-22-015800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122015800/doc4.xml","form_type":"4"}},{"id":2399317,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-02-14T22:02:24.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":4454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date."}],"balance_after":33624,"source":{"system":"sec-edgar","filing":"0001209191-22-009389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009389/doc4.xml","form_type":"4"}},{"id":2399316,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-02-14T22:02:24.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":3565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date."}],"balance_after":29170,"source":{"system":"sec-edgar","filing":"0001209191-22-009389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009389/doc4.xml","form_type":"4"}},{"id":2399315,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2022-02-14T22:02:24.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date."}],"balance_after":25605,"source":{"system":"sec-edgar","filing":"0001209191-22-009389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009389/doc4.xml","form_type":"4"}},{"id":2484294,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-12-06T21:29:27.000Z","date":"2021-12-03","kind":"tax_withholding","acquired":false,"shares":2414,"price":62.69,"value":151333.66,"ownership":{"direct":true},"balance_after":23085,"source":{"system":"sec-edgar","filing":"0001209191-21-068109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121068109/doc4.xml","form_type":"4"}},{"id":2787582,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2021-03-16T20:17:19.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":7267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/12/2021."}],"balance_after":7267,"derivative":{"exercise_price":68.1,"expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":7267},"source":{"system":"sec-edgar","filing":"0001209191-21-020776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020776/doc4.xml","form_type":"4"}},{"id":2787581,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-16T20:17:19.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":261,"price":68.1,"value":17774.1,"ownership":{"direct":true},"balance_after":25499,"source":{"system":"sec-edgar","filing":"0001209191-21-020776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020776/doc4.xml","form_type":"4"}},{"id":2787580,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-16T20:17:19.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":179,"price":68.1,"value":12189.9,"ownership":{"direct":true},"balance_after":25760,"source":{"system":"sec-edgar","filing":"0001209191-21-020776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020776/doc4.xml","form_type":"4"}},{"id":2787579,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-16T20:17:19.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":2411,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25939,"source":{"system":"sec-edgar","filing":"0001209191-21-020776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020776/doc4.xml","form_type":"4"}},{"id":2816146,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-03T21:12:41.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":4212,"price":69.0956,"value":291030.6672,"ownership":{"direct":true},"balance_after":23528,"source":{"system":"sec-edgar","filing":"0001209191-21-016835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121016835/doc4.xml","form_type":"4"}},{"id":2827733,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-01T22:55:48.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":1669,"price":69.43,"value":115878.67,"ownership":{"direct":true},"balance_after":27740,"source":{"system":"sec-edgar","filing":"0001209191-21-015363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121015363/doc4.xml","form_type":"4"}},{"id":2827732,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2021-03-01T22:55:48.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":2288,"price":69.52,"value":159061.76,"ownership":{"direct":true},"balance_after":29409,"source":{"system":"sec-edgar","filing":"0001209191-21-015363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121015363/doc4.xml","form_type":"4"}},{"id":2957107,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer & Sec"}}],"security":"Common Stock","published_at":"2020-12-04T21:12:06.000Z","date":"2020-12-03","kind":"tax_withholding","acquired":false,"shares":1515,"price":54.92,"value":83203.8,"ownership":{"direct":true},"balance_after":31697,"source":{"system":"sec-edgar","filing":"0001209191-20-061790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120061790/doc4.xml","form_type":"4"}},{"id":3207047,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-17T20:15:17.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":14390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020."}],"balance_after":14390,"derivative":{"exercise_price":43.39,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":14390},"source":{"system":"sec-edgar","filing":"0001209191-20-019564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019564/doc4.xml","form_type":"4"}},{"id":3207046,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2020-03-17T20:15:17.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":434,"price":43.39,"value":18831.26,"ownership":{"direct":true},"balance_after":33212,"source":{"system":"sec-edgar","filing":"0001209191-20-019564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019564/doc4.xml","form_type":"4"}},{"id":3207045,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2020-03-17T20:15:17.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":2881,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33646,"source":{"system":"sec-edgar","filing":"0001209191-20-019564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019564/doc4.xml","form_type":"4"}},{"id":3207044,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2020-03-17T20:15:17.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":179,"price":43.39,"value":7766.81,"ownership":{"direct":true},"balance_after":30765,"source":{"system":"sec-edgar","filing":"0001209191-20-019564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019564/doc4.xml","form_type":"4"}},{"id":3234822,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2020-03-03T21:39:42.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":1678,"price":52.1,"value":87423.8,"ownership":{"direct":true},"balance_after":30944,"source":{"system":"sec-edgar","filing":"0001209191-20-015243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120015243/doc4.xml","form_type":"4"}},{"id":3267926,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2020-02-18T21:53:07.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":1581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date."}],"balance_after":32622,"source":{"system":"sec-edgar","filing":"0001209191-20-010217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010217/doc4.xml","form_type":"4"}},{"id":3351477,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2019-12-05T21:07:01.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":4007,"price":61.6222,"value":246920.1554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $61.58 to $61.69."}],"balance_after":31041,"source":{"system":"sec-edgar","filing":"0001209191-19-059284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119059284/doc4.xml","form_type":"4"}},{"id":3351476,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2019-12-05T21:07:01.000Z","date":"2019-12-03","kind":"tax_withholding","acquired":false,"shares":1515,"price":60.49,"value":91642.35,"ownership":{"direct":true},"balance_after":35048,"source":{"system":"sec-edgar","filing":"0001209191-19-059284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119059284/doc4.xml","form_type":"4"}},{"id":3594138,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-15T21:28:25.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":8845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019."}],"balance_after":8845,"derivative":{"exercise_price":55.91,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":8845},"source":{"system":"sec-edgar","filing":"0001209191-19-019777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019777/doc4.xml","form_type":"4"}},{"id":3594137,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2019-03-15T21:28:25.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":1977,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36563,"source":{"system":"sec-edgar","filing":"0001209191-19-019777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019777/doc4.xml","form_type":"4"}},{"id":3615363,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2019-03-05T21:33:53.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":17851,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34586,"source":{"system":"sec-edgar","filing":"0001209191-19-016527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119016527/doc4.xml","form_type":"4"}},{"id":3742296,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corp VP, Gen Counsel & Sec"}}],"security":"Common Stock","published_at":"2018-12-06T21:17:23.000Z","date":"2018-12-03","kind":"grant","acquired":true,"shares":16735,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16735,"source":{"system":"sec-edgar","filing":"0001209191-18-061250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118061250/doc4.xml","form_type":"4"}},{"id":3882131,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-06-27T21:04:24.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":41000,"derivative":{"exercise_price":24.98,"expiration_date":"2026-04-28","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-039681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118039681/doc4.xml","form_type":"4"}},{"id":3882130,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2018-06-27T21:04:24.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":1556,"price":54.594,"value":84948.264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-039681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118039681/doc4.xml","form_type":"4"}},{"id":3882129,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2018-06-27T21:04:24.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":8444,"price":53.638,"value":452919.272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1556,"source":{"system":"sec-edgar","filing":"0001209191-18-039681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118039681/doc4.xml","form_type":"4"}},{"id":3882128,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2018-06-27T21:04:24.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":10000,"price":24.98,"value":249800.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-039681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118039681/doc4.xml","form_type":"4"}},{"id":3978679,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-03-30T15:40:26.000Z","date":"2018-03-28","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 3, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":51000,"derivative":{"exercise_price":24.98,"expiration_date":"2026-04-28","underlying":"Class A Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-18-022180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118022180/doc4.xml","form_type":"4"}},{"id":3978678,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2018-03-30T15:40:26.000Z","date":"2018-03-28","kind":"sale","acquired":false,"shares":24000,"price":50,"value":1200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 26, 2018, which is intended to comply with Rule 10b5-1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-022180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118022180/doc4.xml","form_type":"4"}},{"id":3978677,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2018-03-30T15:40:26.000Z","date":"2018-03-28","kind":"exercise","acquired":true,"shares":24000,"price":24.98,"value":599520.0,"ownership":{"direct":true},"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001209191-18-022180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118022180/doc4.xml","form_type":"4"}},{"id":4090948,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":82044,"kind":"person","name":"Schwartz Eric","position":1,"cik":"0001329100","reported_name":"Schwartz Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP and General Counsel"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-01-24T21:16:08.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":40000,"derivative":{"exercise_price":43.77,"expiration_date":"2028-01-22","underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-005092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118005092/doc4.xml","form_type":"4"}}]}